Qiagen N.V. (QGEN) - Cash on Hand per Share

Qiagen Corp - graphic logo of issuer QGEN

The estimated cash per share for Qiagen N.V. (QGEN), which currently stands at 4.04, demonstrates the liquidity of Qiagen N.V. (QGEN) amid falling demand for COVID tests and pricing pressure. The company is implementing eco-packaging and solar energy to reduce its environmental impact. Meanwhile, academic freedom and generous funding allow the firm to retain leading biologists on staff.

Qiagen Corp - QGEN Cash per Share (period 07/04/2022 - 11/20/2026)

Comprehensive metric breakdowns and analytics for qiagen.com (QGEN)

- current quotes and average value forecast:
- market capitalization indicators:
- cash availability and cash flow indicators:
Comprehensive company analysis:QGEN - Qiagen Group
Product sample of Qiagen N.V.

This metric determines the volume of liquid assets per security, allowing for an assessment of the balance between financial stability and capital efficiency. The current value of 4.04, analyzed through cash per share, confirms the status of Qiagen N.V. (QGEN) as a flawless leader in molecular diagnostics, whose conservative cash policy guarantees the fundamental reliability of the business.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share IONS|RGEN - Cash on Hand per Share|Cash Funds per Share Avidity RNA|Cash per Share CRISPR Therapeutics Corp CRSP|GeneDx Corp - Cash per Share|Ultragenyx Pharma (RARE) - Cash per Single Share|beamtx.com (BEAM) - Cash Funds per Share|SRPT: Cash Calculated per Single Share|Cash per Single Share TWST|TXG - Cash Funds Volume per Share|Cash per Share NTLA|Cash Funds Calculated per Share Stoke Therapeutics|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology